• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

形态磁共振成像特征作为脑转移瘤的预后指标。

Morphological MRI features as prognostic indicators in brain metastases.

机构信息

Mathematical Oncology Laboratory (MOLAB), University of Castilla-La Mancha, Ciudad Real, Spain.

Sanchinarro University Hospital, HM Hospitales, Madrid, Spain.

出版信息

Cancer Imaging. 2024 Aug 20;24(1):111. doi: 10.1186/s40644-024-00753-0.

DOI:10.1186/s40644-024-00753-0
PMID:39164779
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11334491/
Abstract

BACKGROUND

Stereotactic radiotherapy is the preferred treatment for managing patients with fewer than five brain metastases (BMs). However, some lesions recur after irradiation. The purpose of this study was to identify patients who are at a higher risk of failure, which can help in adjusting treatments and preventing recurrence.

METHODS

In this retrospective multicenter study, we analyzed the predictive significance of a set of interpretable morphological features derived from contrast-enhanced (CE) T1-weighted MR images as imaging biomarkers using Kaplan-Meier analysis. The feature sets studied included the total and necrotic volumes, the surface regularity and the CE rim width. Additionally, we evaluated other nonmorphological variables and performed multivariate Cox analysis.

RESULTS

A total of 183 lesions in 128 patients were included (median age 61 [31-95], 64 men and 64 women) treated with stereotactic radiotherapy (57% single fraction, 43% fractionated radiotherapy). None of the studied variables measured at diagnosis were found to have prognostic value. However, the total and necrotic volumes and the CE rim width measured at the first follow-up after treatment and the change in volume due to irradiation can be used as imaging biomarkers for recurrence. The optimal classification was achieved by combining the changes in tumor volume before and after treatment with the presence or absence of necrosis (p <  < 0.001).

CONCLUSION

This study demonstrated the prognostic significance of interpretable morphological features extracted from routine clinical MR images following irradiation in brain metastases, offering valuable insights for personalized treatment strategies.

摘要

背景

立体定向放疗是管理少于 5 个脑转移瘤(BMs)患者的首选治疗方法。然而,一些病灶在照射后会复发。本研究的目的是确定复发风险较高的患者,这有助于调整治疗方案,预防复发。

方法

在这项回顾性多中心研究中,我们使用 Kaplan-Meier 分析,分析了从增强(CE)T1 加权 MR 图像中提取的一组可解释形态特征作为成像生物标志物的预测意义。所研究的特征集包括总坏死体积、表面规则性和 CE 边缘宽度。此外,我们还评估了其他非形态学变量,并进行了多变量 Cox 分析。

结果

共纳入 128 例 183 个病灶患者(中位年龄 61 [31-95],64 名男性和 64 名女性),接受立体定向放疗(57%单次分割,43%分割放疗)。在诊断时测量的所有研究变量均未发现具有预后价值。然而,治疗后第一次随访时测量的总坏死体积和 CE 边缘宽度以及因照射引起的体积变化可作为复发的成像生物标志物。通过结合治疗前后肿瘤体积的变化与坏死的存在与否,可实现最佳分类(p<0.001)。

结论

本研究表明,从脑转移瘤照射后常规临床 MR 图像中提取的可解释形态特征具有预后意义,为个性化治疗策略提供了有价值的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7104/11334491/40369c95183a/40644_2024_753_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7104/11334491/efd2a803ced3/40644_2024_753_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7104/11334491/924c4f27236c/40644_2024_753_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7104/11334491/140d7a8981cb/40644_2024_753_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7104/11334491/40369c95183a/40644_2024_753_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7104/11334491/efd2a803ced3/40644_2024_753_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7104/11334491/924c4f27236c/40644_2024_753_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7104/11334491/140d7a8981cb/40644_2024_753_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7104/11334491/40369c95183a/40644_2024_753_Fig4_HTML.jpg

相似文献

1
Morphological MRI features as prognostic indicators in brain metastases.形态磁共振成像特征作为脑转移瘤的预后指标。
Cancer Imaging. 2024 Aug 20;24(1):111. doi: 10.1186/s40644-024-00753-0.
2
The prognostic value of tumor necrosis in patients undergoing stereotactic radiosurgery of brain metastases.脑转移瘤立体定向放射外科治疗患者中肿瘤坏死的预后价值。
Radiat Oncol. 2013 Jul 3;8:162. doi: 10.1186/1748-717X-8-162.
3
Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.基于直线加速器的立体定向放射外科治疗5个或更多放射性抵抗性黑色素瘤脑转移瘤的潜在作用。
J Neurosurg. 2015 Nov;123(5):1261-7. doi: 10.3171/2014.12.JNS141919. Epub 2015 Jul 3.
4
A predictive model for distinguishing radiation necrosis from tumour progression after gamma knife radiosurgery based on radiomic features from MR images.基于 MR 图像的放射组学特征,建立伽玛刀放射外科治疗后鉴别放射性坏死与肿瘤进展的预测模型。
Eur Radiol. 2018 Jun;28(6):2255-2263. doi: 10.1007/s00330-017-5154-8. Epub 2017 Nov 24.
5
Stereotactic radiosurgery for intracranial hemangiopericytomas: a multicenter study.立体定向放射外科治疗颅内血管外皮细胞瘤:一项多中心研究。
J Neurosurg. 2017 Mar;126(3):744-754. doi: 10.3171/2016.1.JNS152860. Epub 2016 Apr 22.
6
Serial MR imaging of intracranial metastases after radiosurgery.放射外科治疗后颅内转移瘤的系列磁共振成像
Magn Reson Imaging. 1997;15(10):1121-32. doi: 10.1016/s0730-725x(97)00178-1.
7
Impact of regular magnetic resonance imaging follow-up after stereotactic radiotherapy to the surgical cavity in patients with one to three brain metastases.单发至三发脑转移患者立体定向放疗后行手术腔定期磁共振成像随访的影响。
Radiat Oncol. 2019 Mar 14;14(1):45. doi: 10.1186/s13014-019-1252-x.
8
Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.对既往行放射外科治疗后局部复发的脑转移瘤行重复立体定向放射外科治疗作为挽救性治疗。
J Neurosurg. 2017 Jul;127(1):148-156. doi: 10.3171/2016.5.JNS153051. Epub 2016 Aug 5.
9
Transient enlargement of contrast uptake on MRI after linear accelerator (linac) stereotactic radiosurgery for brain metastases.脑转移瘤行直线加速器立体定向放射治疗后MRI上对比剂摄取的短暂增加
Int J Radiat Oncol Biol Phys. 2001 Apr 1;49(5):1339-49. doi: 10.1016/s0360-3016(00)01511-x.
10
Assessment of imaging risks for recurrence after stereotactic radiosurgery for brain metastases (IRRaS-BM).脑转移瘤立体定向放射外科治疗后复发的影像学风险评估(IRRaS-BM)。
BMC Cancer. 2024 Jul 18;24(1):866. doi: 10.1186/s12885-024-12636-5.

本文引用的文献

1
A large open access dataset of brain metastasis 3D segmentations on MRI with clinical and imaging information.一个带有临床和影像信息的大型脑转移瘤 MRI 3D 分割的开放获取数据集。
Sci Data. 2024 Feb 29;11(1):254. doi: 10.1038/s41597-024-03021-9.
2
Volumetric analysis: Rethinking brain metastases response assessment.容积分析:重新思考脑转移瘤的疗效评估
Neurooncol Adv. 2023 Dec 10;6(1):vdad161. doi: 10.1093/noajnl/vdad161. eCollection 2024 Jan-Dec.
3
Dual-center validation of using magnetic resonance imaging radiomics to predict stereotactic radiosurgery outcomes.
使用磁共振成像放射组学预测立体定向放射外科治疗结果的双中心验证
Neurooncol Adv. 2023 May 27;5(1):vdad064. doi: 10.1093/noajnl/vdad064. eCollection 2023 Jan-Dec.
4
A comprehensive dataset of annotated brain metastasis MR images with clinical and radiomic data.带临床和放射组学数据的注释脑转移瘤磁共振成像综合数据集。
Sci Data. 2023 Apr 14;10(1):208. doi: 10.1038/s41597-023-02123-0.
5
Automatic Assessment of Stereotactic Radiation Therapy Outcome in Brain Metastasis Using Longitudinal Segmentation on Serial MRI.使用 MRI 序列的纵向分割自动评估脑转移瘤的立体定向放疗效果。
IEEE J Biomed Health Inform. 2023 Jun;27(6):2681-2692. doi: 10.1109/JBHI.2023.3235304. Epub 2023 Jun 5.
6
Association of Brain Metastases With Survival in Patients With Limited or Stable Extracranial Disease: A Systematic Review and Meta-analysis.脑转移与局限性或稳定性颅外疾病患者生存的相关性:系统评价和荟萃分析。
JAMA Netw Open. 2023 Feb 1;6(2):e230475. doi: 10.1001/jamanetworkopen.2023.0475.
7
Brain metastases from NSCLC treated with stereotactic radiotherapy: prediction mismatch between two different radiomic platforms.非小细胞肺癌脑转移患者采用立体定向放疗治疗:两种不同影像组学平台之间的预测不匹配。
Radiother Oncol. 2023 Jan;178:109424. doi: 10.1016/j.radonc.2022.11.013. Epub 2022 Nov 24.
8
Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions.脑转移瘤:神经肿瘤学会(SNO)关于当前管理和未来方向的共识综述。
Neuro Oncol. 2022 Oct 3;24(10):1613-1646. doi: 10.1093/neuonc/noac118.
9
Radiographic markers of breast cancer brain metastases: relation to clinical characteristics and postoperative outcome.乳腺癌脑转移的影像学标志物:与临床特征及术后结果的关系。
Acta Neurochir (Wien). 2022 Feb;164(2):439-449. doi: 10.1007/s00701-021-05026-4. Epub 2021 Oct 22.
10
EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours.欧洲神经肿瘤学会(EANO)与欧洲肿瘤内科学会(ESMO)实体瘤脑转移患者诊断、治疗及随访临床实践指南
Ann Oncol. 2021 Nov;32(11):1332-1347. doi: 10.1016/j.annonc.2021.07.016. Epub 2021 Aug 6.